{"disease":{"id":"coronary-heart-disease","name":"coronary heart disease"},"drugs":{"marketed":[{"drug_id":"atorvastatin","indication_name":"Primary Prevention of Coronary Heart Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lipitor","generic_name":"atorvastatin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"HMG-CoA reductase","drug_class":"HMG-CoA reductase inhibitor (statin)","quality_score":77,"revenue":"1000.0","mechanism":"Selective competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis."},{"drug_id":"lopid","indication_name":"Reducing risk of developing coronary heart disease in Type IIb patients without history or symptoms of existing coronary heart disease with low HDL-cholesterol, elevated LDL-cholesterol, and elevated triglycerides unresponsive to weight loss, diet, exercise, and other pharmacologic agents","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lopid","generic_name":"Gemfibrozil","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"PPAR-alpha (Peroxisome Proliferator-Activated Receptor Alpha)","drug_class":"Peroxisome Proliferator Receptor alpha Agonist [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"gemfibrozil","indication_name":"Primary Prevention of Coronary Heart Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lopid","generic_name":"GEMFIBROZIL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Transthyretin","drug_class":"Peroxisome Proliferator Receptor alpha Agonist [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"fenofibrate","indication_name":"At increased risk of coronary heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tricor (Micronized)","generic_name":"FENOFIBRATE","company_name":"Salix","drug_phase":"marketed","molecular_target":"PPARα","drug_class":"Peroxisome Proliferator Receptor alpha Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Fenofibrate activates PPARα, enhancing lipolysis and reducing triglycerides, while increasing HDL-cholesterol and uric acid excretion."},{"drug_id":"rosuvastatin","indication_name":"Primary Prevention of Coronary Heart Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Crestor","generic_name":"rosuvastatin","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"HMG-CoA reductase","drug_class":"HMG-CoA reductase inhibitor (statin)","quality_score":74,"revenue":null,"mechanism":"Rosuvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme converting HMG-CoA to mevalonate, a cholesterol precursor."},{"drug_id":"lipitor","indication_name":"Primary Prevention of Coronary Heart Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lipitor","generic_name":"Atorvastatin Calcium","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"3-hydroxy-3-methylglutaryl-coenzyme A reductase","drug_class":"atorvastatin","quality_score":10,"revenue":null,"mechanism":"Lipitor is a selective, competitive inhibitor of HMG-CoA reductase, a key enzyme in cholesterol synthesis."},{"drug_id":"amlodipine","indication_name":"Primary Prevention of Coronary Heart Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norvasc","generic_name":"amlodipine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Voltage-dependent calcium channel gamma-1 subunit, 5-hydroxytryptamine receptor 6","drug_class":"Calcium channel blocker (dihydropyridine)","quality_score":55,"revenue":null,"mechanism":"Long-acting dihydropyridine calcium channel blocker that relaxes vascular smooth muscle, reducing blood pressure and myocardial oxygen demand."},{"drug_id":"lovastatin","indication_name":"Primary Prevention of Coronary Heart Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mevacor","generic_name":"LOVASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"3-hydroxy-3-methylglutaryl-coenzyme A reductase","drug_class":"HMG-CoA Reductase Inhibitor","quality_score":null,"revenue":null,"mechanism":"Mevacor works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol production in the liver."},{"drug_id":"caduet","indication_name":"Multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Caduet","generic_name":"Amlodipine Besylate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channel","drug_class":"Dihydropyridine calcium channel blocker","quality_score":76,"revenue":null,"mechanism":"Calcium channel antagonist inhibiting transmembrane calcium influx into vascular and cardiac muscle."},{"drug_id":"amlodipin","indication_name":"Primary Prevention of Coronary Heart Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Amlodipin","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Voltage-dependent calcium channel gamma-1 subunit, 5-hydroxytryptamine receptor 6","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":10,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02550717","title":"Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)","phase":"","overall_status":"COMPLETED","enrollment_count":398158,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04715594","title":"CONNECT DES Registrty","phase":"","overall_status":"UNKNOWN","enrollment_count":350000,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT03987633","title":"EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Future Genetics Limited","has_results":false},{"nct_id":"NCT05699629","title":"Prospective Coronary Heart Disease Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Shandong First Medical University","has_results":false},{"nct_id":"NCT04584645","title":"A Digital Flu Intervention for People With Cardiovascular Conditions","phase":"NA","overall_status":"COMPLETED","enrollment_count":49138,"lead_sponsor_name":"Evidation Health","has_results":true},{"nct_id":"NCT03934957","title":"Hamburg City Health Study - a German Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":45000,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT03133689","title":"Alcohol Consumption and Coronary Heart Disease Onset","phase":"","overall_status":"COMPLETED","enrollment_count":35132,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT07149688","title":"Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Beijing Anzhen Hospital","has_results":false},{"nct_id":"NCT06001073","title":"Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics","phase":"","overall_status":"RECRUITING","enrollment_count":25000,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT06335901","title":"Clinical Characteristics and Outcomes of Coronary Heart Disease","phase":"","overall_status":"COMPLETED","enrollment_count":20000,"lead_sponsor_name":"Xinjiang Medical University","has_results":false},{"nct_id":"NCT03945968","title":"The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.","phase":"","overall_status":"RECRUITING","enrollment_count":16000,"lead_sponsor_name":"Russian Federation of Anesthesiologists and Reanimatologists","has_results":false},{"nct_id":"NCT07534410","title":"The Prognostic Value of Cardiopulmonary Exercise Testing Parameters in Patients With Coronary Heart Disease: A Retrospective Cohort Study(CPETPCAD)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Xinjiang Medical University","has_results":false},{"nct_id":"NCT06855394","title":"Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":13000,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT06265714","title":"The IndONEsia ICCU Registry: a Multicenter Cohort of Intensive Cardiovascular Care Units Patients in Indonesia","phase":"","overall_status":"COMPLETED","enrollment_count":12950,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT03872401","title":"Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12301,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT07312318","title":"AI-Driven Dynamic Prediction of Non-Target Lesion Progression After PCI: A Chinese Multicenter Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT07353762","title":"Coronary Imaging and Metabolic Indicators-Based Risk Prediction Model for Coronary Artery Disease(CMI-RiskCAD)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10960,"lead_sponsor_name":"Beijing Anzhen Hospital","has_results":false},{"nct_id":"NCT06216847","title":"Clinical Outcomes of Patients With Coronary Artery Disease","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT06253481","title":"Genetics of Cardiovascular Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Center for Strategic Planning, of the Federal Medical and Biological Agency","has_results":false},{"nct_id":"NCT05081115","title":"Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Fatebenefratelli Hospital","has_results":false},{"nct_id":"NCT06472908","title":"Efficacy and Safety of Colchicine After PCI","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":8862,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT04624854","title":"Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":8250,"lead_sponsor_name":"Harbin Medical University","has_results":false},{"nct_id":"NCT03051048","title":"System Delay and Clinical Outcome Among Chinese Patients With AMI Treated With Reperfusion Therapy (MOODY Study)","phase":"","overall_status":"COMPLETED","enrollment_count":8000,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT03928119","title":"reGional Network for Acute Myocardial Infarction","phase":"NA","overall_status":"UNKNOWN","enrollment_count":7102,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT04676100","title":"International CR Registry","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":7000,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT00829660","title":"Acarbose Cardiovascular Evaluation Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":6526,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT06743672","title":"Development of a Novel Risk Prediction Tool for Emergency Department Patients Symptoms of Coronary Artery Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":6500,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT04492384","title":"Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients","phase":"","overall_status":"COMPLETED","enrollment_count":6396,"lead_sponsor_name":"Eurasian Association of Therapists","has_results":false},{"nct_id":"NCT07230756","title":"Coronary Heart Disease Complicated With Ischemic Mitral Regurgitation in China","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT06190834","title":"Relationship Between High-Density Lipoprotein Subtypes and Coronary Heart Disease Prognosis.","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Beijing Tsinghua Chang Gung Hospital","has_results":false},{"nct_id":"NCT03461367","title":"CTO Registry From Insight of IVUS in Fuwai Hospital","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT07031531","title":"Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":4900,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT04950699","title":"Peking University & University of Michigan Study of MI and Atherosclerosis","phase":"","overall_status":"COMPLETED","enrollment_count":4700,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT03217006","title":"Randomization of Single vs Multiple Arterial Grafts","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4300,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT05166447","title":"Twenty-year Follow-up of the Inter99 Cohort","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":4000,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT03797339","title":"Multi-omics Study of Clinical Endpoints in CHD","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT03650127","title":"Returning Genome and Metabolome Data to FinTerveys 2017 Participants: P5.fi FinTerveys Study","phase":"","overall_status":"UNKNOWN","enrollment_count":3449,"lead_sponsor_name":"Markus Perola","has_results":false},{"nct_id":"NCT03216733","title":"SORT OUT X - Combo Stent Versus ORSIRO Stent","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3148,"lead_sponsor_name":"Aarhus University Hospital Skejby","has_results":false},{"nct_id":"NCT03189199","title":"A Registry Study on Safety Surveillance of Dazhuhongjingtian (a Chinese Medicine Injection) Used in China","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"China Academy of Chinese Medical Sciences","has_results":false},{"nct_id":"NCT05698732","title":"Coroflex® ISAR NEO PMCF Study","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Fundación EPIC","has_results":false},{"nct_id":"NCT05705973","title":"Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Terumo Europe N.V.","has_results":false},{"nct_id":"NCT05099692","title":"CHD Patient's Concern on Cardiac Rehabilitation","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT06541691","title":"Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Rajaie Cardiovascular Medical and Research Center","has_results":false},{"nct_id":"NCT02093845","title":"Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2800,"lead_sponsor_name":"Aarhus University Hospital Skejby","has_results":false},{"nct_id":"NCT07110415","title":"Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":2708,"lead_sponsor_name":"SPH Qingdao Growful Pharmacetical Co.,Ltd","has_results":false},{"nct_id":"NCT05653765","title":"Prognostic Value of the AMR Measured After PPCI in STEMI Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2663,"lead_sponsor_name":"Henan Institute of Cardiovascular Epidemiology","has_results":false},{"nct_id":"NCT03852082","title":"Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2600,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT02668250","title":"Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality","phase":"NA","overall_status":"COMPLETED","enrollment_count":2495,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT05133921","title":"The Clinical Efficacy and Safety of Drug-coated Balloon","phase":"","overall_status":"COMPLETED","enrollment_count":2487,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT04328090","title":"Evaluation of the Potential Impact of Computerized Antimicrobial Stewardship","phase":"NA","overall_status":"COMPLETED","enrollment_count":2473,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}